Koyfin Home > Directory > Health Care > Acadia Pharmaceutica > Total Debt / (EBITDA-CAPEX)

Acadia Pharmaceutica Total Debt / (EBITDA-CAPEX) Chart (ACAD)

Acadia Pharmaceutica annual/quarterly Total Debt / (EBITDA-CAPEX) from 2010 to 2020.
  • Acadia Pharmaceutica Total Debt / (EBITDA-CAPEX) for the quarter ending June 06, 2020 was $0m a -26.90% increase of 0m year over year
  • Acadia Pharmaceutica Total Debt / (EBITDA-CAPEX) for the last 12 months ending June 06, 2020 was $0m a -13.76% increase of 0m year over year
  • Acadia Pharmaceutica Annual Total Debt / (EBITDA-CAPEX) for 2019 was $0m a 96.53% decrease of 0m from 2018
  • Acadia Pharmaceutica Annual Total Debt / (EBITDA-CAPEX) for 2011 was $0m a 450.53% decrease of 0m from 2010
  • Acadia Pharmaceutica Annual Total Debt / (EBITDA-CAPEX) for 2010 was $0m
Other Ratios Metrics:
  • Acadia Pharmaceutica Total Debt / Capital for the quarter ending September 09, 2012 was $0m a -708.88% decrease of 0m year over year
  • Acadia Pharmaceutica Other Liabilities for the quarter ending December 12, 2018 was $2m a 49.81% increase of 1m year over year
  • Acadia Pharmaceutica Total Debt / Equity for the quarter ending September 09, 2012 was $0m a -710.06% decrease of 0m year over year
View Chart On Koyfin

Quarterly ACAD Total Debt / (EBITDA-CAPEX) Data

06/2020$0m
03/2020$0m
12/2019$0m
09/2019$0m
06/2019$0m
03/2019$0m
09/2012$0m
06/2012$0m
03/2012$0m
12/2011$0m

Annual ACAD Total Debt / (EBITDA-CAPEX) Data

2019$0m
2011$0m
2010$0m